Oral Imatinib Reduces Mortality in Hospitalized COVID-19 Patients Through Endothelial Barrier Protection and Immunomodulation

Research output: Contribution to journalMeeting AbstractAcademic

Original languageEnglish
JournalAmerican journal of respiratory and critical care medicine
Volume205
Publication statusPublished - 1 May 2022

Cite this